Trial · NCT02079246
Results by group13
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 13 of 13
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Number of Treatment Emergent Adverse Events (TEAEs) in the OLEX | Idalopirdine 60 mg | 2130 | TEAEs | ||
| Number of TEAEs in the OLEX-MEM | Idalopirdine 60 mg + Memantine | 93 | TEAEs | ||
| Change in Cognition | Idalopirdine 60 mg (OLEX); Patients From lead-in Study 14681A | 3.01 | Standard Error 0.22 | units on a scale | |
| Change in Cognition | Idalopirdine 60 mg (OLEX); Patients From lead-in Study 14862A | 2.67 | Standard Error 0.23 | units on a scale | |
| Clinical Global Impression Score | Idalopirdine 60 mg (OLEX); Patients From lead-in Study 14681A | 4.58 | Standard Error 0.005 | units on a scale | |
| Clinical Global Impression Score | Idalopirdine 60 mg (OLEX); Patients From lead-in Study 14862A | 4.61 | Standard Error 0.05 | units on a scale | |
| Change in Daily Functioning | Idalopirdine 60 mg (OLEX); Patients From lead-in Study 14681A | -3.71 | Standard Error 0.28 | units on a scale | |
| Change in Daily Functioning | Idalopirdine 60 mg (OLEX); Patients From lead-in Study 14862A | -3.88 | Standard Error 0.32 | units on a scale | |
| Change in Behavioural Disturbance | Idalopirdine 60 mg (OLEX); Patients From lead-in Study 14681A | 1.80 | Standard Error 0.35 | units on a scale | |
| Change in Behavioural Disturbance | Idalopirdine 60 mg (OLEX); Patients From lead-in Study 14862A | 1.36 | Standard Error 0.34 | units on a scale | |
| Change in Cognitive Aspects of Mental Function | Idalopirdine 60 mg (OLEX); Patients From lead-in Study 14681A | -1.28 | Standard Error 0.10 | units on a scale | |
| Change in Cognitive Aspects of Mental Function | Idalopirdine 60 mg (OLEX); Patients From lead-in Study 14862A | -1.02 | Standard Error 0.11 | units on a scale | |
| Change in Cognitive Aspects of Mental Function | Idalopirdine 60 mg + Memantine (OLEX-MEM) | -0.55 | Standard Error 0.26 | units on a scale |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02079246/results